Frontiers in Immunology
Centre for Precision Health
National Natural Science Foundation of China (No. 81900347) / Provincial Natural Science Foundation of Guangdong (No.2019A1515011817)
As modern medicine began to emerge at the turn of the 20th century, glycan-based therapies advanced. DNA- and protein-centered therapies became widely available. The research and development of structurally defined carbohydrates have led to new tools and methods that have sparked interest in the therapeutic applications of glycans. One of the latest omics disciplines to emerge in the contemporary post-genomics age is glycomics. In addition, to providing hope for patients and people with different health conditions through a deeper understanding of the mechanisms of common complex diseases, this new specialty in system sciences has much to offer to communities involved in the development of diagnostics and therapeutics in medicine and life sciences.This review focuses on recent developments that have pushed glycan-based therapies into the spotlight in medicine and the technologies powering these initiatives, which we can take as the most significant success of the 21st century.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Mahara, G., Tian, C., Xu, X., & Zhu, J. (2022). Breakthrough of glycobiology in the 21st century. Frontiers in Immunology, 13, Article 1071360. https://doi.org/10.3389/fimmu.2022.1071360